SOURCE: Modern Mobility Aids, Inc.
TORONTO, ON--(Marketwired - Mar 19, 2014) - Toronto based Nevada firm Modern Mobility Aids Inc. (OTC Pink: MDRM) (PINKSHEETS: MDRM) is pleased to appoint Gilbert Sharpe as Executive Advisor to the Company. Gilbert, the former long-time Director of the Legal Branch of the Ontario Ministry of Health and Long-Term Care, brings invaluable experience from a distinguished 30-year career in legal practice and advisory roles. His background in public policy, private sector involvement and college regulatory work is a great asset to Fasken Martineau's national Health Law Group. Through Gilbert's involvement with the Ministry of Health since 1975, and associated work with numerous ministries and agencies of the Ontario government as well as federal departments, Gilbert has been involved continuously with important legal issues and policy matters affecting health care, including the development of legislation and policies to improve the health care system. As well, he has been an advocate for educational forums to promote ongoing and effective exchange of information related to new initiatives.
Since leaving the Ontario government, Gilbert has continued to work on numerous health law and policy matters for various clients, both in the private and public sectors.
Gilbert holds several professorships (Professor, Faculty of Health Sciences, McMaster University; Professor, Faculty of Medicine, University of Toronto) as well as other positions including President of the Canadian Institute of Law and Medicine and Editor-in-Chief of Health Law in Canada.
Commenting on the Company's newly appointed Legal advisor, Mr. Declan French, CEO, remarks, "We are excited to have Mr. Gilbert Sharpe on our advisory team as Gilbert brings three decades of experience with Health Canada and government regulation. The Company plans to leverage its expertise in pursuing opportunities in the growing medical marijuana industry."
In February 2014 MDRM experienced a rapid expansion in the life sciences and health care industry with a clear focus on the production of medical marijuana. MDRM's mandate is to acquire companies within the biopharma and alternative medicine sectors targeting both innovative research and development as well as scalable licensed cannabis manufacturing capacity.
The national legalization of medical marijuana by the Canadian Government has created opportunity for cannabis production and sale as Canada is currently implementing a new licensing platform which will create a new rapid growth industry.